In This Section
CPM Webinar Series: Creating and Running an Ethical IP Law Firm: A Survival Guide For Patent & Trademark Practitioners - Part 1
October 6, 2022 12:30 PM to 2:00 PM
Introduction and Overview of Legal and Ethical Duties IP Practitioners Owe to Clients, the Public, and the USPTO
This first part of AIPLA’s six-part webinar series lays the foundation for creating and running an ethical IP firm. During this inaugural session, explore who you may be working with, employing, and partnering with when designing and running an IP law firm and how each of these roles and positions can impact your practice and practice areas.
In addition, you will hear about the legal and ethical duties IP practitioners and their law firms owe to their clients, the USPTO (and other tribunals), adverse parties, third parties, and members of the public and how these duties impact your practice and potential for disciplinary action. Practitioner-client relationship formation and termination will also be discussed.
Subsequent parts in this six-part webinar series will build from these overarching principles. Monthly deep dives into specific practice tips will be provided outside of this webinar series through the support of a variety of AIPLA committees – stay tuned for dates, times, and topics.
Presented by: Michael McCabe, McCabe Ali LLC, and Jan Jacobowitz, Legal Ethics Consulting
This program is a FREE, members-only benefit
No CLE
News
-
AIPLA Submits Letter to US Senate Judiciary Committee on Squires Nomination to the USPTO
June 16, 2025
Arlington, VA. June 11, 2025 –The American Intellectual Property Law Association (AIPLA) submitted a letter in response to the nomination of John A. Squires as Director of the United States Patent & Trademark Office (“USPTO”). In view of his impressive background, AIPLA believes Mr. Squires is fully capable of undertaking this important role and appreciates the Senate Judiciary Committee giving this nominee prompt consideration. -
AIPLA Comments on Draft NMPA Measures
June 9, 2025
Arlington, VA. May 17, 2025 –The American Intellectual Property Law Association (AIPLA) submitted comments in response to the National Medical Products Administration’s (NMPA) draft measures on the protection of drug trial data in China. -
AIPLA Comments to the Copyright Office on the CASE Act Study
May 12, 2025
Arlington, VA. May 9, 2025 –The American Intellectual Property Law Association (AIPLA) submitted comments in response to the U.S. Copyright Office Notice of Inquiry and Request for Comments: CASE Act Study (the “Notice”) related to the Copyright Claims Board. -
AIPLA Files Amicus Brief in Pegasystems Inc. v. Appian Corporation
April 29, 2025
Arlington, VA. April 24, 2025 –The American Intellectual Property Law Association (AIPLA) filed an amicus brief with the Supreme Court of Virginia in Pegasystems Inc. v. Appian Corporation, an appeal concerning issues of trade secret misappropriation damages under the Virginia Uniform Trade Secrets Act (VUTSA). -
AIPLA Comments to the USPTO on the WIPO GRTK Treaty
March 21, 2025
Arlington, VA. March 18, 2025 –The American Intellectual Property Law Association (AIPLA) submitted comments on the World Intellectual Property Organization Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge.